EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ubc9‐Mediated SUMOylation of RPL3, an Unappreciated Mechanism against Hepatocyte Senescence by Repressing the DHX9‐p16 Axis

Hao Xie, Zhichao Gao, Xin Liu, Shiyi Zhang, Yuhan Wang, Jia Gao, Ping Qi, Lu Zhang, Jiawei Zhao, Tian Xiong, Teng Huang, Jia Song und 11 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202510240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Hao Xie und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital…. Hauptthemen laut MEDLINE: Hepatocytes, Sumoylation, Ubiquitin-Conjugating Enzymes, Cellular Senescence. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Key Laboratory of Endocrine and Metabolic Diseases of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although Ubc9‐mediated SUMOylation are recognized to regulate the multiple aspects of hepatic biological processes, its impact on hepatic senescence and metabolic dysfunction‐associated steatotic liver disease (MASLD), however, is yet to be fully addressed. Herein noted an age‐dependent decrease of hepatic Ubc9 expression is first noted along with an escalated decrease of protein SUMOylation, which is coupled with enhanced senescent marker expressions both in humans and mice. Interestingly, Ubc9 is dispensable for liver development at the embryonic stage. However, Ubc9 deficiency in hepatocytes rendered mice with an exacerbated hepatic aging phenotype and more susceptible to fatty liver disease and steatohepatitis following the challenge of a methionine‐ and choline‐deficient (MCD)‐diet. Ii is further demonstrated that nuclear ribosomal protein L3 (RPL3) interacts with DExD/H‐box (DDX/DHX) helicases (DHX9), which then recruits RNA polymerase II to the p16 promoter to transcribe its expression, thereby exacerbating the hepatocyte aging process. However, Ubc9‐mediated SUMOylation prevents RPL3 nuclear translocation, by which it represses the expression of senescent markers such as p16 to attenuate the hepatic aging process. Together, the study highlights that Ubc9‐mediated SUMOylation of RPL3 could be an unappreciated mechanism against hepatic aging in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesSumoylationUbiquitin-Conjugating EnzymesCellular SenescenceRibosomal ProteinsCyclin-Dependent Kinase Inhibitor p16DEAD-box RNA HelicasesUbiquitin-Conjugating Enzyme UBC9AnimalsMiceHumansMaleLiverMice, Inbred C57BLRibosomal Protein L3

Stichwörter der Autor:innen

DHX9SUMOylationagingmetabolic dysfunction‐associated steatotic liver disease (MASLD)ribosomal protein L3 (RPL3)

Substanzen

Ubiquitin-Conjugating Enzyme UBC9Ubiquitin-Conjugating EnzymesRibosomal ProteinsCyclin-Dependent Kinase Inhibitor p16DEAD-box RNA HelicasesRpl3 protein, mouseRibosomal Protein L3

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, the Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technolog…
  • Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
  • Department of Interventional Radiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
  • The Center for Obesity and Metabolic Health, Affiliated Hospital of Southwest Jiaotong University, the Third People's Hospital of Chengdu, 82 Qinglong Road, Chengdu, Sichuan, 610031, China.

ORCID-Profile: Cong-Yi Wang

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Key Laboratory of Endocrine and Metabolic Diseases of Shanxi Province
  • Fundamental Research Funds for the Central Universities, HUST
  • Research and Innovative Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital
  • Continuous Funding Program for High-Level Research Achievements at Shanxi Bethune Hospital
  • National Key Research and Development Program of China

Zitieren

APA

Xie, H., Gao, Z., Liu, X., Zhang, S., Wang, Y., Gao, J., Qi, P., Zhang, L., Zhao, J., Xiong, T., Huang, T., Song, J., Yu, Q., Zhang, S., Liu, Y., Yang, P., Al-Motawa, M. S., Gong, Q., Dong, J., …, & Wang, C. Y. (2026). Ubc9‐Mediated SUMOylation of RPL3, an Unappreciated Mechanism against Hepatocyte Senescence by Repressing the DHX9‐p16 Axis. Advanced Science. https://doi.org/10.1002/advs.202510240

Vancouver

Xie H, Gao Z, Liu X, Zhang S, Wang Y, Gao J, et al. Ubc9‐Mediated SUMOylation of RPL3, an Unappreciated Mechanism against Hepatocyte Senescence by Repressing the DHX9‐p16 Axis. Advanced Science. 2026. doi:10.1002/advs.202510240

BibTeX
@article{Xie2026,
  author = {Xie, Hao and Gao, Zhichao and Liu, Xin and Zhang, Shiyi and Wang, Yuhan and Gao, Jia and Qi, Ping and Zhang, Lu and Zhao, Jiawei and Xiong, Tian and Huang, Teng and Song, Jia and Yu, Qilin and Zhang, Shu and Liu, Yanjun and Yang, Ping and Al-Motawa, Maryam S and Gong, Quan and Dong, Junfeng and Yin, Hao and Sun, Fei and Liu, Shiwei and Wang, Cong-Yi},
  title = {Ubc9‐Mediated SUMOylation of RPL3, an Unappreciated Mechanism against Hepatocyte Senescence by Repressing the DHX9‐p16 Axis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202510240}
}
Kostenlos starten →